Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Titel:
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Auteur:
Simpson, Eric L. Silverberg, Jonathan I. Thyssen, Jacob P. Viguier, Manuelle Thaçi, Diamant de Bruin-Weller, Marjolein Weidinger, Stephan Chan, Gary DiBonaventura, Marco Biswas, Pinaki Feeney, Claire Koulias, Christopher Cork, Michael J.